Factors such as increase in cardiovascular disease incidence and increasing elderly population are driving the market growth. However, side effects of diltiazem is likely to hamper the growth of the market.
Heart diseases are mostly observed in elderly people due to their weak immunity and major other health problems. The general aging factors lead to stiffening the heart and blood vessels that lead to heart disorders. As the age grows, the systolic blood pressure also rises, and it can cause cardiovascular disease. Thus, high blood pressure is a common cause of heart conditions in people aged 75 years and above. Coronary artery disease and heart failure are the next caused conditions. Although the incidence of arrhythmias is encompassing people of all age groups, its incidence is rising significantly among elderly people.
Top Companies Analysis-
Bausch Health
Teva Pharmaceutical Industries Ltd
Mylan N.V
Athenex
Pfizer, Inc,
Glenmark
Sandoz (Novartis Ag)
Sun Pharmaceutical Company Ltd
Hikma Pharmaceuticals
Zydus Pharmaceuticals
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Industry based on various segments. It also provides Industry size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Industry by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The Diltiazem Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Diltiazem market in these regions.
Product Type-Based Insights
Based on product type, the market is segmented into capsules, injection, and tablets. In 2021, the tablets segment held the largest share of the market, whereas the capsules segment is expected to witness the fastest CAGR during 2021 to 2028.
Application -Based Insights
Based on application, the market is segmented into angina, hypertension, and others. In 2021, the hypertension segment held the largest share of the market, whereas the angina segment is expected to grow at the fastest CAGR during the coming years.
The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.
Geographic Segment Covered in the Report:
TABLE OF CONTENTS
- Introduction
- Key Takeaways
- Research Methodology
- Diltiazem Market Landscape
- Diltiazem Market - Key Market Dynamics
- Diltiazem Market - Global Market Analysis
- Diltiazem Market - Revenue And Forecasts To 2028 - Type
- Diltiazem Market - Revenue And Forecasts To 2028 - Application
- Diltiazem Market Revenue And Forecasts To 2028 - Geographical Analysis
- Industry Landscape
- Diltiazem Market, Key Company Profiles
- Appendix
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, and Chemicals
Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek